Skip to content

Ketamine used durning cesarean delivery to prevent postpartum depression: a randomized controlled trial

Ketamine used durning cesarean delivery to prevent postpartum depression: a randomized controlled trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022464
Enrollment
Unknown
Registered
2019-04-12
Start date
2019-06-27
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postpartum depression

Interventions

Experimental group:inject ketamine

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1) undergoing cesarean delivery in Shengjing hospital; 2) the age of the pregnant is = 20 and = 40 years, the Maternal weight is > 50kg and 150cm and < 180cm; 3) the birth age is = 37 weeks and = 42 weeks 4)the birth weight is =2500 g and = 4000 g.

Exclusion criteria

Exclusion criteria: 1) the pregnant has experienced depression before; 2) the pregnant has experienced domestic violence before; 3) the pregnant with a serious obstetric complication or serious foundational diseases; 4) the new born has serious genetic or congenital diseases; 5) multiple pregnancy.

Design outcomes

Secondary

MeasureTime frame
numerical rating scale;nausea and vomiting;sleep duration;

Primary

MeasureTime frame
Edinburgh Postnatal Depression Scale;

Countries

China

Contacts

Public ContactJiaxin Yao

Shengjing Hospital of China Medical Universityity

1293920621@qq.com+86 18809809875

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026